Johnson & Johnson Family of Companies
NEWS
Johnson & Johnson has become the next big pharma player to be accused in New York State’s Department of Financial Services opioid industry probe.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 4, 2020.
Janssen Pharmaceutical of Johnson & Johnson made a strategic call to halt development of pimodivir, an antiviral treatment for influenza A.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 21, 2020.
J&J said the acquisition will allow its subsidiary, Janssen Pharmaceutical, to broaden its leadership in immune-mediated diseases and drive further growth through expansion into autoantibody-driven disease.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 5, 2020.
This morning Johnson & Johnson announced preclinical data that showed its lead vaccine candidate protected against infection with SARS-CoV-2, the virus that causes COVID-19.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 31, 2020.
JOBS
IN THE PRESS